VanEck Biotech ETF (BBH)
161.47
-0.99 (-0.61%)
At close: Mar 04, 2025, 11:17 AM
BBH Holdings List
As of Mar 3, 2025
The VanEck Biotech ETF holds 26 different assets
and the largest one in the portfolio is Amgen Inc., making up 17.49% of
the total.
| Rank | Symbol | Name | Price | % Change | Shares | % Weight |
|---|---|---|---|---|---|---|
| 1 | Amgen Inc. | 314.75 | +1.28% | 218.15K | 17.49% | |
| 2 | Gilead Sciences... | 114.81 | -1.02% | 465.86K | 13.86% | |
| 3 | Vertex Pharmace... | 482.29 | -0.21% | 94.89K | 11.85% | |
| 4 | Regeneron Pharm... | 685.65 | +0.11% | 34.05K | 6.19% | |
| 5 | argenx SE | 620.04 | -0.41% | 31.81K | 5.17% | |
| 6 | IQVIA Holdings ... | 181.07 | -2.04% | 86.26K | 4.24% | |
| 7 | Natera, Inc. | 137.13 | -4.18% | 103.31K | 4.18% | |
| 8 | Alnylam Pharmac... | 239.30 | -1.74% | 58.68K | 3.77% | |
| 9 | ICON Public Lim... | 181.96 | -1.54% | 63.86K | 3.16% | |
| 10 | Biogen Inc. | 144.09 | +1.68% | 82.21K | 3.01% | |
| 11 | Illumina, Inc. | 82.71 | -1.77% | 114.01K | 2.63% | |
| 12 | BeiGene, Ltd. | 184.71 | +0.49% | 35.48K | 2.51% | |
| 13 | BioNTech SE | 110.33 | -1.10% | 84.36K | 2.48% | |
| 14 | Insmed Incorpor... | 75.69 | -0.79% | 110.69K | 2.35% | |
| 15 | Neurocrine Bios... | 112.00 | -2.17% | 70.94K | 2.19% | |
| 16 | Sarepta Therape... | 101.45 | +0.23% | 69.53K | 1.93% | |
| 17 | Moderna, Inc. | 29.79 | -1.59% | 231.1K | 1.86% | |
| 18 | Bio-Techne Corp... | 59.01 | -3.56% | 106.99K | 1.72% | |
| 19 | Incyte Corporat... | 68.46 | -2.56% | 85.9K | 1.64% | |
| 20 | Charles River L... | 162.89 | -0.37% | 36.3K | 1.56% | |
| 21 | Qiagen N.V. | 37.81 | -1.06% | 150.54K | 1.50% | |
| 22 | BioMarin Pharma... | 70.55 | -0.66% | 78.04K | 1.45% | |
| 23 | Repligen Corpor... | 149.89 | -3.53% | 33.14K | 1.37% | |
| 24 | Exact Sciences ... | 47.28 | -0.57% | 92.62K | 1.14% | |
| 25 | Cytokinetics, I... | 42.94 | +0.12% | 50.48K | 0.60% | |
| 26 | Other/cash | n/a | n/a | 434.97K | 0.11% |